Etesian Wealth Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,847
Closed -$305K 143
2024
Q3
$305K Sell
4,847
-1,150
-19% -$67.1K 0.14% 123
2024
Q2
$354K Sell
5,997
-918
-13% -$57.4K 0.2% 98
2024
Q1
$552K Hold
6,915
0.32% 86
2023
Q4
$546K Sell
6,915
-350
-5% -$24.9K 0.33% 85
2023
Q3
$507K Sell
7,265
-9
-0.1% -$638 0.34% 84
2023
Q2
$503K Buy
7,274
+204
+3% +$14.5K 0.33% 84
2023
Q1
$525K Buy
7,070
+144
+2% +$12.1K 0.35% 84
2022
Q4
$645K Buy
+6,926
New +$668K 0.47% 72

Other funds holding CVS

Etesian Wealth Advisors's CVS Position: Q4 2024 in Review

Etesian Wealth Advisors sold out of CVS Health (CVS) in Q4 2024, closing a stake of 4,847 shares — an estimated $305K sold.

Etesian Wealth Advisors first reported a position in CVS in Q4 2022 and held it in 8 quarters. The position peaked at $645K in Q4 2022. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Etesian Wealth Advisors reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Etesian Wealth Advisors sold 4,847 CVS Health shares in Q4 2024, an estimated $305K.
  • Etesian Wealth Advisors first reported a position in CVS Health in Q4 2022 and held it in 8 quarters.
  • Etesian Wealth Advisors's CVS Health position peaked at $645K in Q4 2022.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Etesian Wealth Advisors's 13F filing for Q4 2024, filed 27 Jan 2025.